Filing Details
- Accession Number:
- 0001181431-12-034874
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-06-06 09:13:15
- Reporting Period:
- 2012-06-04
- Filing Date:
- 2012-06-06
- Accepted Time:
- 2012-06-06 09:13:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1235612 | Laurie Brlas | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-06-04 | 3,351 | $34.45 | 20,664 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-06-04 | 3,351 | $102.21 | 17,313 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-06-04 | 3,053 | $39.62 | 20,366 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-06-04 | 3,053 | $102.16 | 17,313 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Director Stock Option Right to Buy | Disposition | 2012-06-04 | 3,351 | $0.00 | 3,351 | $34.45 |
| Common Stock | Director Stock Option Right to Buy | Disposition | 2012-06-04 | 3,053 | $0.00 | 3,053 | $39.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-11-13 | 2018-11-13 | No | 4 | M | Direct |
| 0 | 2010-11-09 | 2019-11-09 | No | 4 | M | Direct |
Footnotes
- The price in column 4 is a weighted average. The prices actually received ranged from $102.19 to $102.238. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- The price in column 4 is a weighted average. The prices actually received ranged from $102.13 to $102.19. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
Billionaire Hedge Funds
